To Be Discontinued Tablet Other
Doxylamine Succinate and Pyr · 242 days since initial FDA posting
Brand: DOXYLAMINE SUCCINATE AND PYRIDOXINE HYDROCHLORIDE
FDA lists Doxylamine Succinate and Pyr as To Be Discontinued (Mylan Pharmaceuticals Inc., a Viatris Company).
No availability text on this FDA row.
Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Doxylamine Succinate and Pyridoxine Hydrochloride Tablet, Delayed Release
- Manufacturer
- Mylan Pharmaceuticals Inc., a Viatris Company
- Dosage Form
- Tablet
- Presentation
- Doxylamine Succinate and Pyridoxine Hydrochloride, Tablet, Delayed Release, 10 mg; 10 mg (NDC 0378-4615-01)
- Package NDC
- 0378-4615-01
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jan 12, 2026
- Last Updated
- Jan 12, 2026
- Therapeutic Category
- Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
A business decision was made to discontinue manufacture of the drug.
FDA reason on file: A business decision was made to discontinue manufacture of the drug. General shortage guidance lives on the tracker hub.